Vermillion, Inc. (NASDAQ:VRML) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.73 and traded as high as $0.77. Vermillion shares last traded at $0.72, with a volume of 12,470 shares trading hands.
The company has a 50-day moving average of $0.65 and a 200-day moving average of $0.73. The company has a debt-to-equity ratio of 0.10, a current ratio of 4.54 and a quick ratio of 4.53.
Vermillion (NASDAQ:VRML) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.04) earnings per share for the quarter. The company had revenue of $1.29 million during the quarter. Vermillion had a negative net margin of 353.32% and a negative return on equity of 163.08%.
Vermillion Company Profile (NASDAQ:VRML)
Vermillion, Inc, together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women.
Featured Story: Buy Rating
Receive News & Ratings for Vermillion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vermillion and related companies with MarketBeat.com's FREE daily email newsletter.